Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms EP-1215 |
Target |
Action inhibitors |
Mechanism EBNA1 inhibitors(Epstein-Barr nuclear antigen 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Epstein-Barr virus associated Nasopharyngeal Carcinoma | Preclinical | - | 18 Feb 2026 |





